These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 28954482)

  • 41. Enterotype May Drive the Dietary-Associated Cardiometabolic Risk Factors.
    de Moraes AC; Fernandes GR; da Silva IT; Almeida-Pititto B; Gomes EP; Pereira AD; Ferreira SR
    Front Cell Infect Microbiol; 2017; 7():47. PubMed ID: 28280715
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids.
    Fu J; Bonder MJ; Cenit MC; Tigchelaar EF; Maatman A; Dekens JA; Brandsma E; Marczynska J; Imhann F; Weersma RK; Franke L; Poon TW; Xavier RJ; Gevers D; Hofker MH; Wijmenga C; Zhernakova A
    Circ Res; 2015 Oct; 117(9):817-24. PubMed ID: 26358192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deciphering the Human Gut Microbiome of Urolithin Metabotypes: Association with Enterotypes and Potential Cardiometabolic Health Implications.
    Romo-Vaquero M; Cortés-Martín A; Loria-Kohen V; Ramírez-de-Molina A; García-Mantrana I; Collado MC; Espín JC; Selma MV
    Mol Nutr Food Res; 2019 Feb; 63(4):e1800958. PubMed ID: 30471188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microbial Community of Healthy Thai Vegetarians and Non-Vegetarians, Their Core Gut Microbiota, and Pathogen Risk.
    Ruengsomwong S; La-Ongkham O; Jiang J; Wannissorn B; Nakayama J; Nitisinprasert S
    J Microbiol Biotechnol; 2016 Oct; 26(10):1723-1735. PubMed ID: 27381339
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gut microbiome as a biomarker of cardiometabolic disorders.
    Gózd-Barszczewska A; Kozioł-Montewka M; Barszczewski P; Młodzińska A; Humińska K
    Ann Agric Environ Med; 2017 Sep; 24(3):416-422. PubMed ID: 28954482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity.
    Kasselman LJ; Vernice NA; DeLeon J; Reiss AB
    Atherosclerosis; 2018 Apr; 271():203-213. PubMed ID: 29524863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
    Miele L; Giorgio V; Alberelli MA; De Candia E; Gasbarrini A; Grieco A
    Curr Cardiol Rep; 2015 Dec; 17(12):120. PubMed ID: 26497040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Gastrointestinal Microbiota of the Common Marmoset (Callithrix jacchus).
    Sheh A
    ILAR J; 2020 Dec; 61(2-3):188-198. PubMed ID: 33620078
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gut microbiome as a novel cardiovascular therapeutic target.
    Singh V; Yeoh BS; Vijay-Kumar M
    Curr Opin Pharmacol; 2016 Apr; 27():8-12. PubMed ID: 26828626
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physical exercise, gut, gut microbiota, and atherosclerotic cardiovascular diseases.
    Chen J; Guo Y; Gui Y; Xu D
    Lipids Health Dis; 2018 Jan; 17(1):17. PubMed ID: 29357881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulatory role of gut microbiota in cholesterol and glucose metabolism: Potential implications for atherosclerotic cardiovascular disease.
    Roessler J; Leistner DM; Landmesser U; Haghikia A
    Atherosclerosis; 2022 Oct; 359():1-12. PubMed ID: 36126379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gut Microbiota: A New Marker of Cardiovascular Disease.
    Garcia-Rios A; Torres-Peña JD; Perez-Jimenez F; Perez-Martinez P
    Curr Pharm Des; 2017; 23(22):3233-3238. PubMed ID: 28317481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gut microbiota and cardiovascular disease: opportunities and challenges.
    Kazemian N; Mahmoudi M; Halperin F; Wu JC; Pakpour S
    Microbiome; 2020 Mar; 8(1):36. PubMed ID: 32169105
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intestinal Immunity and Gut Microbiota as Therapeutic Targets for Preventing Atherosclerotic Cardiovascular Diseases.
    Yamashita T; Kasahara K; Emoto T; Matsumoto T; Mizoguchi T; Kitano N; Sasaki N; Hirata K
    Circ J; 2015; 79(9):1882-90. PubMed ID: 26212124
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.